Related Experiment Video
Updated: Mar 17, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Calciphylaxis - A case study in a patient with Maori heritage
Lawrence Kingi1, Roger Grech1, Michael Lam1
1Counties Manukau District Health Board, Middlemore Hospital, Private Bag 93311, Otahuhu, Auckland 1640, New Zealand.
Calciphylaxis, a rare condition causing non-healing ulcers and sepsis, has a high mortality rate. Early diagnosis and multidisciplinary management are crucial for patients, especially those on renal dialysis.
Area of Science:
- Nephrology
- Dermatology
- Vascular Medicine
Background:
- Calciphylaxis is a rare, severe complication often seen in patients with end-stage renal disease.
- It presents as painful necrotic skin lesions, leading to significant morbidity and mortality.
- Early recognition is critical for effective management and improving patient outcomes.
Observation:
- A case of calciphylaxis is presented in a New Zealand Maori patient undergoing renal dialysis.
- The patient exhibited typical non-healing tissue ulceration.
- Sepsis was a significant complicating factor.
Findings:
- Calciphylaxis is associated with a very high mortality rate.
- Risk factors for early diagnosis require vigilance from healthcare professionals.
- A multidisciplinary team approach is valuable for managing calciphylaxis.
Implications:
- Highlights the importance of recognizing calciphylaxis in renal dialysis patients.
- Emphasizes the need for prompt diagnosis and intervention to reduce mortality.
- Underscores the benefit of collaborative, team-based care in managing complex cases.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Drug toxicity: Idiosyncratic Reactions
Cardiomyopathy III: Hypertrophic Cardiomyopathy